Generic Soltamox Availability
SOLTAMOX (tamoxifen citrate - solution;oral)
Manufacturer: MIDATECH PHARMA US
Approval date: October 29, 2005
Strength(s): EQ 10MG BASE/5ML
Has a generic version of Soltamox been approved?
No. There is currently no therapeutically equivalent version of Soltamox available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Soltamox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Oral liquid medicine solution
Issued: October 3, 2000
Inventor(s): Tully; Roger Edward
Assignee(s): Akzo Nobel N.V.
Found is a pharmaceutical preparation which provides Tamoxifen Citrate in a liquid dosage form, viz. as an oral solution. The finding is based on a solvent comprising the following components: (a) of from 10% to 20% by weight of ethanol, (b) of from 10% to 60% by weight of a glycol; and (c) water, optionally containing additives, in a volume percentage adding up to 100% by volume. A preferred additive is sorbitol.Patent expiration dates:
- June 26, 2018✓
- June 26, 2018
More about Soltamox (tamoxifen)
- Other brands: Nolvadex
Related treatment guides
|Drug Patent||A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.|
|Drug Exclusivity||Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.|